The Claim

Elevated serum levels of indoxyl sulfate, p-cresyl sulfate, and phenylacetylglutamine are consistently associated with declining kidney function in diabetic kidney disease and promote renal injury through the induction of oxidative stress, inflammation, and fibrosis via activation of NADPH oxidase and NF-κB pathways.

Source: Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
2score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Higher levels of three specific waste products in the blood—indoxyl sulfate, p-cresyl sulfate, and phenylacetylglutamine—are linked to worsening kidney function in people with diabetic kidney disease and directly contribute to kidney damage by triggering oxidative stress, inflammation, and tissue scarring through activation of NADPH oxidase and NF-κB pathways.

See the scientific wording

Elevated serum levels of protein-bound uremic toxins—indoxyl sulfate, p-cresyl sulfate, and phenylacetylglutamine—are consistently associated with declining kidney function in diabetic kidney disease, and these toxins promote renal injury by inducing oxidative stress, inflammation, and fibrosis through activation of NADPH oxidase and NF-κB pathways.

Why this might work

Bacteria in the gut break down protein from food into toxic chemicals that enter the blood. When the kidneys fail, these toxins build up and enter kidney cells, where they turn on enzymes that produce harmful reactive molecules. These molecules trigger a chain reaction that turns on inflammatory signals and causes scar tissue to form, damaging the kidney over time.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds

    When kidneys aren't working well in people with diabetes, gut bacteria make harmful waste products from protein that build up in the blood and hurt the kidneys by causing swelling and scarring. This study shows that’s exactly what’s happening.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.